Masashi Nakaura
Keine laufenden Positionen mehr
Profil
Masashi Nakaura served as Chief Executive Officer at Taisho Pharmaceuticals Philippines, Inc., Director-Singapore, Malaysia & Indonesia Business at PT Bristol Myers Squibb Indonesia, General Director & Director at DHG Pharmaceutical JSC, and Operational Director at PT Taisho Pharmaceutical Indonesia.
Nakaura received an undergraduate degree from Sophia University in 1981.
Ehemalige bekannte Positionen von Masashi Nakaura
| Unternehmen | Position | Ende |
|---|---|---|
| DHG PHARMACEUTICAL | Vorstandsvorsitzender | - |
PT Bristol Myers Squibb Indonesia
 PT Bristol Myers Squibb Indonesia Pharmaceuticals: MajorHealth Technology The Group's principal activities are manufacturing and selling pharmaceutical and health care products. The products comprise of ethical products, over-the-counter products and oncology products. Brands include, Counterpain, Counterpain Cool, Tempra, Tempra Forte, Baraclude, Taxol and Sprycel. The Group's plant is located in Cilangkap, Depok. | Corporate Officer/Principal | - |
| Taisho Pharmaceuticals Philippines, Inc. | Vorstandsvorsitzender | - |
| TAISHO PHARMACEUTICAL INDONESIA TBK PT | Geschäftsführer | - |
Ausbildung von Masashi Nakaura
| Sophia University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DHG PHARMACEUTICAL | Health Technology |
| Private Unternehmen | 3 |
|---|---|
PT Taisho Pharmaceutical Indonesia
 PT Taisho Pharmaceutical Indonesia Pharmaceuticals: MajorHealth Technology PT Taisho Pharmaceutical Indonesia engages in the development, registration, process, production and sale of chemical, pharmaceutical, and health care products. Its products include Tempra, Analgesic Balm and Theragran-M. The company was founded on July 8, 1970 and is headquartered in Jakarta, Indonesia. | Health Technology |
PT Bristol Myers Squibb Indonesia
PT Bristol Myers Squibb Indonesia Pharmaceuticals: MajorHealth Technology The Group's principal activities are manufacturing and selling pharmaceutical and health care products. The products comprise of ethical products, over-the-counter products and oncology products. Brands include, Counterpain, Counterpain Cool, Tempra, Tempra Forte, Baraclude, Taxol and Sprycel. The Group's plant is located in Cilangkap, Depok. | Health Technology |
| Taisho Pharmaceuticals Philippines, Inc. |
